Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from Amoeba SA ( (FR:ALMIB) ).
Amoéba has announced its continued participation in the European SAGROPIA project, which aims to reduce conventional pesticide use in agriculture by 50% through integrated pest management strategies. This initiative aligns with the European ‘Farm to Fork’ roadmap, enhancing food security and sustainability while maintaining farm competitiveness. Amoéba contributes its biocontrol product ‘AXPERA’ to combat diseases in potato and sugar beet cultivation, positioning itself in a market with significant economic potential.
More about Amoeba SA
Amoéba is a French industrial greentech company specializing in the development of natural microbiological solutions using patented amoeba technology. The company focuses on creating sustainable alternatives to conventional pesticides, targeting high-potential markets in agriculture.
YTD Price Performance: -2.90%
Average Trading Volume: 2,203
Technical Sentiment Consensus Rating: Sell
Current Market Cap: €41.76M
For a thorough assessment of ALMIB stock, go to TipRanks’ Stock Analysis page.